Yahoo · Sep 10, 2026
Centene Stock: Is CNC Outperforming the Healthcare Sector?
Centene has outpaced the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.

NYSE · CNC
Healthcare · Medical - Healthcare Plans
$67.66
Down-$1.77 (-2.55%)
Updated Sep 16, 2026, 1:28 PM
SID Score
6.6/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CNC closed at $67.66 after 20 trading sessions, up 3.74% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $68.50 | $68.62 | $67.05 | $67.66 | 3.58M |
| Sep 14, 2026 | $67.31 | $69.63 | $67.15 | $69.41 | 4.1M |
| Sep 11, 2026 | $65.70 | $66.85 | $64.52 | $66.42 | 3.63M |
| Sep 10, 2026 | $65.50 | $68.205 | $65.26 | $65.40 | 4.63M |
| Sep 9, 2026 | $64.44 | $64.84 | $61.81 | $64.06 | 4.48M |
| Sep 8, 2026 | $66.16 | $66.50 | $64.50 | $64.58 | 4.35M |
| Sep 4, 2026 | $66.77 | $68.22 | $66.7675 | $67.04 | 2.93M |
| Sep 3, 2026 | $67.50 | $68.83 | $66.85 | $68.02 | 3.59M |
| Sep 2, 2026 | $65.40 | $67.885 | $65.40 | $67.34 | 4.83M |
| Sep 1, 2026 | $64.72 | $66.47 | $64.69 | $65.23 | 4.56M |
| Aug 31, 2026 | $65.39 | $65.39 | $63.42 | $64.34 | 8.79M |
| Aug 28, 2026 | $65.41 | $65.74 | $64.28 | $64.75 | 2.53M |
| Aug 27, 2026 | $65.04 | $66.21 | $64.66 | $65.33 | 3.65M |
| Aug 26, 2026 | $65.00 | $67.68 | $64.98 | $65.47 | 3.6M |
| Aug 25, 2026 | $65.95 | $65.95 | $64.60 | $65.00 | 4.34M |
| Aug 24, 2026 | $64.79 | $66.10 | $64.52 | $65.65 | 3.49M |
| Aug 21, 2026 | $64.07 | $65.16 | $64.03 | $65.02 | 3.15M |
| Aug 20, 2026 | $63.73 | $64.87 | $63.47 | $64.14 | 3.27M |
| Aug 19, 2026 | $65.55 | $65.695 | $64.26 | $64.70 | 2.88M |
| Aug 18, 2026 | $64.89 | $65.94 | $64.72 | $65.22 | 3.41M |
The latest Smart Investors Daily articles mentioning CNC.
CNC research
Company profile and research snapshot.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | Argus Research | Buy | — |
| Aug 4, 2026 | JP Morgan | Neutral | — |
| Aug 3, 2026 | Bernstein | Outperform | — |
| Jul 29, 2026 | Barclays | Overweight | — |
| Jul 29, 2026 | Baird | Neutral | — |
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Centene has outpaced the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.
Yahoo · Sep 9, 2026
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
Yahoo · Sep 9, 2026
Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), today announced a $2 million investment in Stanislaus Equity Partners, Inc. (STEP) to help more residents access safe, stable, affordable housing. The multi-year grant will provide flexible gap financing for 50 affordable housing projects already in the local pipeline, helping move shovel-ready developments closer to completion.
Yahoo · Sep 9, 2026
UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CNC.